In a step that can accelerate the launch of the Russian single dose vaccine Covid-19 Light Sputnik, the subject expert committee has told the Laboratories Dr.
Reddy that he did not need to conduct a separate phase-III trial in India.
Data from the Russian Phase-III trial will be enough to provide marketing authorization, he said.